Stany Zjednoczone - angielski - NLM (National Library of Medicine)

remedyrepack inc. - minocycline hydrochloride (unii: 0020414e5u) (minocycline - unii:fyy3r43wgo) - minocycline hydrochloride capsules, usp are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms:             rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox and tick fevers caused by rickettsiae .             respiratory tract infections caused by mycoplasma pneumoniae .             lymphogranuloma venereum caused by chlamydia trachomatis .             psittacosis (ornithosis) due to chlamydophila psittaci .             trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence.             inclusion conjunctivitis caused by chlamydia trachomatis .             nongonococcal urethritis, endocervical, or rectal infections in adults caused by ureaplasma urealyticum or chlamydia trachomatis .             relapsing fever due to borrelia recurrentis .             chancroid caused by haemophilus ducreyi .             plague due to yersinia pestis .             tularemia due to francisella tularensis .             cholera caused by vibrio cholerae .             campylobacter fetus infections caused by campylobacter fetus .             brucellosis due to brucella species (in conjunction with streptomycin).             bartonellosis due to bartonella bacilliformis .             granuloma inguinale caused by klebsiella granulomatis . minocycline is indicated for the treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:                          escherichia coli.             enterobacter aerogenes.             shigella species.             acinetobacter species.             respiratory tract infections caused by haemophilus influenzae .             respiratory tract and urinary tract infections caused by klebsiella species. minocycline hydrochloride capsules, usp are indicated for the treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:             upper respiratory tract infections caused by streptococcus pneumoniae .             skin and skin structure infections caused by staphylococcus aureus . (note: minocycline is not the drug of choice in the treatment of any type of staphylococcal infection.) when penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following infections:             uncomplicated urethritis in men due to neisseria gonorrhoeae and for the treatment of other gonococcal infections.             infections in women caused by neisseria gonorrhoeae .             syphilis caused by treponema pallidum subspecies pallidum .             yaws caused by treponema pallidum subspecies pertenue .             listeriosis due to listeria monocytogenes .             anthrax due to bacillus anthracis .             vincent's infection caused by fusobacterium fusiforme .             actinomycosis caused by actinomyces israelii .             infections caused by clostridium species. in acute intestinal amebiasis , minocycline may be a useful adjunct to amebicides. in severe acne , minocycline may be useful adjunctive therapy. oral minocycline is indicated in the treatment of asymptomatic carriers of neisseria meningitidis to eliminate meningococci from the nasopharynx. in order to preserve the usefulness of minocycline in the treatment of asymptomatic meningococcal carriers, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed to establish the carrier state and the correct treatment. it is recommended that the prophylactic use of minocycline be reserved for situations in which the risk of meningococcal meningitis is high. oral minocycline is not indicated for the treatment of meningococcal infection . although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by mycobacterium marinum . to reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride capsules, usp and other antibacterial drugs, minocycline hydrochloride capsules, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines or to any of the components of the product formulation.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

quality care products, llc - doxycycline (unii: n12000u13o) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules, usp and other antibacterial drugs, doxycycline capsules, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline capsules, usp are indicated for the treatment of the following infections: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. respiratory tract infections caused by mycoplasma pneumoniae. lymphogranuloma venereum caused by chlamydia trachomatis. psittacosis (ornithosis) caused by chlamydophila psittaci. trachoma caused by chlamydia trachomatis, although the infectious agent is not always eliminated as judged by immunofluorescence. inclusion conjunctivitis caused by chlamydia  trachomatis. uncomplicated urethral, endocervical or rectal infections in adults caused by chlamydia trachomatis. nongonococcal urethritis caused by ureaplasma  urealyticum. relapsing fever due to borrelia recurrentis. doxycycline capsules, usp are also indicated for the treatment of infections caused by the following gram-negative microorganisms: chancroid caused by haemophilus ducreyi. plague due to yersinia pestis . tularemia due to francisella tularensis . cholera caused by vibrio cholerae . campylobacter fetus infections caused by campylobacter fetus . brucellosis   due to brucella species (in conjunction with streptomycin). bartonellosis due to bartonella bacilliformis. granuloma inguinale caused by klebsiella granulomatis. because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline capsules, usp are indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: escherichia coli enterobacter aerogenes shigella species acinetobacter species respiratory tract infections caused by haemophilus influenzae. respiratory tract and urinary tract infections caused by klebsiella species. doxycycline capsules, usp are indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: upper respiratory infections caused by streptococcus pneumoniae . anthrax due to bacillus anthracis, including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of the following infections: uncomplicated gonorrhea caused by neisseria gonorrhoeae. syphilis caused by treponema  pallidum. yaws caused by treponema pallidum subspecies pertenue. listeriosis due to listeria  monocytogenes. vincent's infection caused by fusobacterium    fusiforme. actinomycosis caused by actinomyces israelii. infections caused by clostridium species. in acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides. in severe acne, doxycycline may be useful adjunctive therapy. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

remedyrepack inc. - doxycycline (unii: n12000u13o) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. respiratory tract infections caused by mycoplasma pneumoniae. lymphogranuloma venereum caused by chlamydia trachomatis. psittacosis (ornithosis) caused by chlamydophila psittaci. trachoma caused by chlamydia trachomatis, although the infectious agent is not always eliminated as judged by immunofluorescence. inclusion conjunctivitis caused by chlamydia trachomatis. uncomplicated urethral, endocervical or rectal infections in adults caused by chlamydia trachomatis. nongonococcal urethritis caused by ureaplasma urealyticum. relapsing fever due to borrelia recurrentis. doxycycline is also indicated for the treatment of infections caused by the following gram-negative microorganisms: chancroid caused by haemophilus ducreyi. plague due to yersinia pestis . tularemia due to francisella tularensis . cholera caused by vibrio cholerae . campylobacter fetus infections caused by campylobacter fetus . brucellosis due to brucella species (in conjunction with streptomycin). bartonellosis due to bartonella bacilliformis. granuloma inguinale caused by klebsiella granulomatis. because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline is indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: escherichia coli enterobacter aerogenes shigella species acinetobacter species respiratory tract infections caused by haemophilus influenzae. respiratory tract and urinary tract infections caused by klebsiella species. doxycycline is indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: upper respiratory infections caused by streptococcus pneumoniae . anthrax due to bacillus anthracis, including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of the following infections: uncomplicated gonorrhea caused by neisseria gonorrhoeae. syphilis caused by treponema pallidum. yaws caused by treponema pallidum subspecies pertenue. listeriosis due to listeria monocytogenes. vincent's infection caused by fusobacterium fusiforme. actinomycosis caused by actinomyces israelii. infections caused by clostridium species. in acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides. in severe acne, doxycycline may be useful adjunctive therapy. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

a-s medication solutions - doxycycline (unii: n12000u13o) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline capsules usp and other antibacterial drugs, doxycycline capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline capsules usp is indicated for the treatment of the following infections: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. respiratory tract infections caused by mycoplasma pneumoniae . lymphogranuloma venereum caused by chlamydia trachomatis. psittacosis (ornithosis) caused by chlamydophila psittaci. trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated as judged by immunofluorescence. inclusion conjunctivitis caused by chlamydia trachomatis . uncomplicated urethral, endocervical or rectal infections in adults caused by chlamydia trachomatis . nongonococcal urethritis caused by ureaplasma urealyticum . relapsing fever due to borrelia recurrentis . doxycycline capsules usp is also indicated for the treatment of infections caused by the following gram-negative microorganisms: chancroid caused by haemophilus ducreyi. plague due to yersinia pestis. tularemia due to francisella tularensis. cholera caused by vibrio cholerae. campylobacter fetus infections caused by campylobacter fetus. brucellosis due to brucella species (in conjunction with streptomycin). bartonellosis due to bartonella bacilliformis. granuloma inguinale caused by klebsiella granulomatis. because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline capsules usp is indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: escherichia coli enterobacter aerogenes shigella species acinetobacter species respiratory tract infections caused by haemophilus influenzae. respiratory tract and urinary tract infections caused by klebsiella species. doxycycline capsules usp is indicated for treatment of infections caused by the following gram-positive microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: upper respiratory infections caused by streptococcus pneumoniae anthrax due to bacillus anthracis, including inhalational anthrax (post-exposure); to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of the following infections: uncomplicated gonorrhea caused by neisseria gonorrhoeae . syphilis caused by treponema pallidum. yaws caused by treponema pallidum subspecies pertenue . listeriosis due to listeria monocytogenes. vincent’s infection caused by fusobacterium fusiforme. actinomycosis caused by actinomyces israelii . infections caused by clostridium species. in acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides. in severe acne, doxycycline may be useful adjunctive therapy. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

amneal pharmaceuticals ny llc - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae , mycoplasma pneumoniae (eaton agent, and klebsiella sp. ) - skin and soft tissue infections caused by streptococcus pyogenes , staphylococcus aureaus . (tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.) - infections caused by rickettsia including rocky mountain spotted fever, typhus group infections, q fever, rickettsialpox. - psittacosis caused by chlamydophila psittaci . - infections caused by chlamydia trachomatis such as uncomplicated urethral, endocervical or rectal infections, inclusion conjunctivitis, trachoma, and lymphogranuloma venereum. - granuloma inquinale caused by klebsiella granulomatis . - relapsing fever caused by borrelia sp. - bartonellosis caused by bartonella bacilliformis . - chancroid caused by hemophilus ducreyi . - tularemia caused by francisella tularensis . - plaque caused by yersinia pestis . - cholera caused by vibrio cholerae . - brucellosis caused by brucella species (tetracycline may be used in conjunction with an aminoglycoside). - infections due to campylobacter fetus . - as adjunctive therapy in intestinal amebiasis caused by entamoeba histolytica . - urinary tract infections caused by susceptible strains of escherichia coli , klebsiella , etc. - other infections caused by susceptible gram-negative organisms such as e. coli , enterobacter aerogenes , shigella sp. , acinetobacter sp. , klebsiella sp. , and bacteroides sp . - in severe acne, adjunctive therapy with tetracycline may be useful. when penicillin is contraindicated, tetracyclines are alternative drugs in the treatment of the following infections: - syphilis and yaws caused by treponema pallidum and pertenue , respectively, - vincent’s infection caused by fusobacterium fusiforme , - infections caused by neisseria gonorrhoeae , - anthrax caused by bacillus anthracis , - infections due to listeria monocytogenes , - actinomycosis caused by actinomyces species, - infections due to clostridium species. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

apotex corp. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline hyclate tablets are indicated for treatment of rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsial pox, and tick fevers caused by rickettsiae . doxycycline hyclate tablets are indicated for treatment of the following sexually transmitted infections: - uncomplicated urethral, endocervical or rectal infections caused by chlamydia trachomatis . - nongonococcal urethritis caused by ureaplasma urealyticum . - lymphogranuloma venereum caused by chlamydia trachomatis . - granuloma inguinale caused by klebsiella granulomatis . - uncomplicated gonorrhea caused by neisseria gonorrhoeae . - chancroid caused by haemophilus ducreyi . doxycycline hyclate tablets are indicated for treatment of the following respiratory tract infections: - respiratory tract infections caused by mycoplasma pneumoniae . - psittacosis (ornithosis) caused by chlamydophila psittaci . - because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. - doxycycline is indicated for treatment of infections caused by the following microorganisms, when bacteriological testing indicates appropriate susceptibility to the drug: - respiratory tract infections caused by haemophilus influenzae. - respiratory tract infections caused by klebsiella species . - upper respiratory infections caused by streptococcus pneumoniae . doxycycline hyclate tablets are indicated for treatment of the following specific bacterial infections: - relapsing fever due to borrelia recurrentis . - plague due to yersinia pestis . - tularemia due to francisella tularensis . - cholera caused by vibrio cholerae . - campylobacter fetus infections caused by campylobacter fetus . - brucellosis due to brucella species (in conjunction with streptomycin). - bartonellosis due to bartonella bacilliformis . because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline hyclate tablets are indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriological testing indicates appropriate susceptibility to the drug: - escherichia coli - enterobacter aerogenes - shigella species - acinetobacter species - urinary tract infections caused by klebsiella species. doxycycline hyclate tablets are indicated for treatment of the following ophthalmic infections: - trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated as judged by immunofluorescence. - inclusion conjunctivitis caused by chlamydia trachomatis . doxycycline hyclate tablets are indicated for the treatment of anthrax due to bacillus anthracis , including inhalational anthrax (post-exposure); to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis . doxycycline hyclate tablets are indicated as an alternative treatment for the following selected infections when penicillin is contraindicated: - syphilis caused by treponema pallidum . - yaws caused by treponema pallidum subspecies pertenue . - listeriosis due to listeria monocytogenes . - vincent’s infection caused by fusobacterium fusiforme . - actinomycosis caused by actinomyces israelii . - infections caused by clostridium species . in acute intestinal amebiasis, doxycycline hyclate tablets may be a useful adjunct to amebicides. in severe acne, doxycycline hyclate tablets may be useful adjunctive therapy. doxycycline hyclate tablets are indicated for the prophylaxis of malaria due to plasmodium falciparum in short-term travelers (less than 4 months) to areas with chloroquine and/or pyrimethamine-sulfadoxine resistant strains [see dosage and administration (2.4) and patient counseling information (17)] . to reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline hyclate tablets are contraindicated in persons who have shown hypersensitivity to any of the tetracyclines. risk summary doxycycline hyclate tablets, like other tetracycline-class antibacterial drugs, may cause discoloration deciduous teeth, and reversible inhibition of bone growth when administered during the second and third trimester of pregnancy [see warnings and precautions (5.1) and (5.2)]. available data from published studies over decades have not shown a difference in major birth defect risk compared to unexposed pregnancies with doxycycline exposure in the first trimester of pregnancy (see data). there are no available data on the risk of miscarriage following exposure to doxycycline in pregnancy. advise the patient of the potential risk to the fetus if doxycycline hyclate tablets is used during pregnancy. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. data human data a retrospective cohort study of 1,690 pregnant patients who received doxycycline prescriptions in the first trimester of pregnancy compared to an unexposed pregnant cohort showed no difference in the major malformation rate. there is no information on the dose or duration of treatment, or if the patients actually ingested the doxycycline that was prescribed. other published studies on exposure to doxycycline in the first trimester of pregnancy have small sample sizes; however, these studies have not shown an increased risk of major malformations. the use of tetracyclines during tooth development (second and third trimester of pregnancy) may cause permanent discoloration of the teeth (yellow-gray-brown). this adverse reaction is more common during long-term use of the drug but has been observed following repeated short-term courses. [see warnings and precautions (5.1,5.2)]. animal data results of animal studies indicate that tetracyclines cross the placenta, are found in fetal tissues, and can have toxic effects on the developing fetus (often related to retardation of skeletal development). evidence of embryotoxicity also has been noted in animals treated early in pregnancy. risk summary based on available published data, doxycycline is present in human milk. there are no data that inform the levels of doxycycline in breastmilk, the effects on the breastfed infant, or the effects on milk production. because of the potential for serious adverse reactions, including tooth discoloration and inhibition of bone growth, advise patients that breastfeeding is not recommended during treatment with doxycycline hylcate tablets and for 5 days after the last dose. infertility based on findings from a fertility study in animals, doxycycline may impair female and male fertility. the reversibility of this finding is unclear. [see nonclinical toxicology (13.1)]. because of the effects of drugs of the tetracycline-class on tooth development and growth, use doxycycline in pediatric patients 8 years of age or less only when the potential benefits are expected to outweigh the risks in severe or life-threatening conditions (e.g., anthrax, rocky mountain spotted fever), particularly when there are no alternative therapies [see warnings and precautions (5.1,1.1) and dosage and administration (2.1, 2.5)] . clinical studies of doxycycline hyclate tablets did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between the elderly and younger patients.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline for injection, usp and other antibacterial drugs, doxycycline for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline for injection, usp is indicated in infections caused by the following microorganisms: rickettsiae (rocky mountain spotted fever, typhus fever, and the typhus group, q fever, rickettsial pox and tick fevers). mycoplasma pneumoniae (pplo, eaton agent). agents of psittacosis and ornithosis. agents of lymphogranuloma venereum and granuloma inguinale. the spirochetal agent of relapsing fever (borrelia recurrentis). the following gram-negative microorganisms: haemophilus ducreyi (chancroid). yersinia pestis (formerly pasteurella pestis) and francisella tularensis (formerly pasteurella tularensis). bartonella bacilliformis. bacteroides species. vibrio cholerae (formerly vibrio comma) and campylobacter fetus (formerly vibrio fetus). brucella species (in conjunction with streptomycin). because many strains of the following groups of microorganisms have been shown to be resistant to tetracyclines, culture and susceptibility testing are recommended. doxycycline is indicated for treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: escherichia coli. enterobacter aerogenes (formerly aerobacter aerogenes). shigella species. acinetobacter species (formerly mima species and herellea species). haemophilus influenzae (respiratory infections). klebsiella species (respiratory and urinary infections). doxycycline is indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: streptococcus species: up to 44 percent of strains of streptococcus pyogenes and 74 percent of enterococcus faecalis (formerly streptococcus faecalis) have been found to be resistant to tetracycline drugs. therefore, tetracyclines should not be used for streptococcal disease unless the organism has been demonstrated to be sensitive. for upper respiratory infections due to group a beta-hemolytic streptococci, penicillin is the usual drug of choice, including prophylaxis of rheumatic fever. streptococcus pneumoniae (formerly diplococcus pneumoniae). staphylococcus aureus, respiratory, skin and soft tissue infections. tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections. anthrax due to bacillus anthracis, including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: neisseria gonorrhoeae and n. meningitidis. treponema pallidum and treponema pertenue (syphilis and yaws). listeria monocytogenes. clostridium species. fusobacterium fusiforme (vincent's infection). actinomyces species. in acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides. doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - doxycycline (unii: n12000u13o) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules, usp and other antibacterial drugs, doxycycline capsules, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline capsules, usp are indicated for the treatment of the following infections: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. respiratory tract infections caused by mycoplasma pneumoniae . lymphogranuloma venereum caused by chlamydia trachomatis . psittacosis (ornithosis) caused by chlamydophila psittaci . trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated as judged by immunofluorescence. inclusion conjunctivitis caused by chlamydia trachomatis . uncomplicated urethral, endocervical or rectal infections in adults caused by chlamydia trachomatis . nongonococcal urethritis caused by ureaplasma urealyticum . relapsing fever due to borrelia recurrentis . doxycycline capsules, usp are also indicated for the treatment of infections caused by the following gram-negative microorganisms: chancroid caused by haemophilus ducreyi . plague due to yersinia pestis . tularemia due to francisella tularensis . cholera caused by vibrio cholerae . campylobacter fetus infections caused by campylobacter fetus . brucellosis due to brucella species (in conjunction with streptomycin). bartonellosis due to bartonella bacilliformis . granuloma inguinale caused by klebsiella granulomatis. because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline capsules, usp are indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: escherichia coli enterobacter aerogenes shigella species acinetobacter species respiratory tract infections caused by haemophilus influenzae . respiratory tract and urinary tract infections caused by klebsiella species . doxycycline capsules, usp are indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: upper respiratory infections caused by streptococcus pneumoniae . anthrax due to bacillus anthracis , including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis . when penicillin is contraindicated, doxycycline capsules, usp are an alternative drug in the treatment of the following infections: uncomplicated gonorrhea caused by neisseria gonorrhoeae . syphilis caused by treponema pallidum . yaws caused by treponema pallidum subspecies pertenue listeriosis due to listeria monocytogenes . vincent’s infection caused by fusobacterium fusiforme . actinomycosis caused by actinomyces israelii . infections caused by clostridium species . in acute intestinal amebiasis, doxycycline capsules, usp may be a useful adjunct to amebicides. in severe acne, doxycycline capsules, usp may be useful adjunctive therapy. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

a-s medication solutions - doxycycline (unii: n12000u13o) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules, usp and other antibacterial drugs, doxycycline capsules, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline capsules, usp are indicated for the treatment of the following infections: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. respiratory tract infections caused by mycoplasma pneumoniae. lymphogranuloma venereum caused by chlamydia trachomatis. psittacosis (ornithosis) caused by chlamydophila psittaci. trachoma caused by chlamydia trachomatis, although the infectious agent is not always eliminated as judged by immunofluorescence. inclusion conjunctivitis caused by chlamydia  trachomatis. uncomplicated urethral, endocervical or rectal infections in adults caused by chlamydia trachomatis. nongonococcal urethritis caused by ureaplasma  urealyticum. relapsing fever due to borrelia recurrentis. doxycycline capsules, usp are also indicated for the treatment of infections caused by the following gram-negative microorganisms: chancroid caused by haemophilus ducreyi. plague due to yersinia pestis . tularemia due to francisella tularensis . cholera caused by vibrio cholerae . campylobacter fetus infections caused by campylobacter fetus . brucellosis   due to brucella species (in conjunction with streptomycin). bartonellosis due to bartonella bacilliformis. granuloma inguinale caused by klebsiella  granulomatis. because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline capsules, usp are indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: escherichia coli enterobacter aerogenes shigella species acinetobacter species respiratory tract infections caused by haemophilus influenzae. respiratory tract and urinary tract infections caused by klebsiella species. doxycycline capsules, usp are indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: upper respiratory infections caused by streptococcus pneumoniae . anthrax due to bacillus anthracis, including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of the following infections: uncomplicated gonorrhea caused by neisseria gonorrhoeae. syphilis caused by treponema  pallidum. yaws caused by treponema pallidum subspecies pertenue. listeriosis due to listeria  monocytogenes. vincent's infection caused by fusobacterium    fusiforme. actinomycosis caused by actinomyces israelii. infections caused by clostridium species. in acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides. in severe acne, doxycycline may be useful adjunctive therapy. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxycycline hyclate, quantity: 57.7 mg (equivalent: doxycycline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; macrogol 4000 - infections caused by the following microorganisms: mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus): chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents). borreliae (relapsing fever); calymmatobacterium (donovania) granulomatis (granuloma inguinale). infections caused by the following gram-negative microorganisms: vibrio sp. (cholera); brucella sp. (brucellosis, in conjunction with streptomycin); haemophilus ducreyi (chancroid); yersinia pestis (plague); francisella tularensis (tularaemia); bartonella bacilliformis (bartonellosis); bacteroides sp. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: treponema pallidum (syphilis); treponema perenue (yaws); neisseria gonorrhoea (see dosage and administration). doxycycline is not the drug of choice in the treatment of any type of staphylococcal infection of infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, enterococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxycycline should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a b-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice. in acute intestinal amoebiasis doxycycline may be a useful adjunct to amoebicides. in severe acne, doxycycline may be a useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example chloroquine. note: the 50mg tablet is not a paediatric formulation.